vidarabine phosphate has been researched along with Lung Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Both, GW; Dane, A; Martiniello-Wilks, R; Mortensen, E; Russell, PJ; Shaw, JM; Voeks, DJ; Wang, XY | 1 |
Clark, G; Hersh, M; Hutton, JJ; Kuhn, J; Phillips, J; Von Hoff, DD | 1 |
Belt, RJ; Coltman, CA; Costanzi, JJ; Crowley, J; Hynes, HE; Taylor, SA; Von Hoff, DD; Weiss, GR | 1 |
Crowley, J; Hill, JB; Rainey, JM | 1 |
4 other study(ies) available for vidarabine phosphate and Lung Neoplasms
Article | Year |
---|---|
Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer.
Topics: Adenoviridae; Animals; Antimetabolites, Antineoplastic; Apoptosis; Cattle; Cell Proliferation; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Prodrugs; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Purine-Nucleoside Phosphorylase; Transduction, Genetic; Vidarabine Phosphate | 2004 |
Phase I clinical investigation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate (NSC 312887), a new purine antimetabolite.
Topics: Adenocarcinoma; Arabinonucleotides; Drug Evaluation; Female; Humans; Kinetics; Lung Neoplasms; Male; Neoplasms; Vidarabine; Vidarabine Phosphate | 1984 |
Phase II study of fludarabine phosphate for the treatment of advanced non-small cell carcinoma of the lung: a Southwest Oncology Group Study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Arabinonucleotides; Carcinoma; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vidarabine Phosphate | 1986 |
Evaluation of fludarabine phosphate in small cell carcinoma. A Southwest Oncology Group Study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arabinonucleotides; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Vidarabine Phosphate | 1988 |